Zucara Therapeutics Inc.
$550,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2020-2021
Canada
The firm is developing a first-in-class therapeutic agent to prevent dangerously low blood sugar in insulin dependent Type 1 Diabetics. This project aims to demonstrate the same effect in Type 2 diab...